Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PINBALL: Paricalcitol with Chemotherapy in Metastatic Pancreatic Cancer
NCT04054362Phase 2Completed
- Sponsor
- Barts Health NHS Trust
- Start
- Nov 2018
- Primary completion
- Feb 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of paricalcitol in pancreatic ductal adenocarcinoma (PDAC), sponsored by Barts Health NHS Trust. Started Nov 2018; status: completed.
02
Drugs
paricalcitol
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT04054362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04054362.